OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
April 01, 2010
Biotechnology company Genzyme reported that FDA notified the company that it intends to take enforcement action to ensure that products are made in compliance with good manufacturing practice (GMP) regulations.
March 25, 2010
President Obama signed into law major healthcare reform following the passage of the bill by the House of Representatives.
March 18, 2010
AstraZeneca signed a license and supply agreement with the drug company and manufacturer Torrent Pharmaceuticals.
March 11, 2010
The Pharmaceutical Research and Manufacturers of America, along with eight other pharmaceutical, business, and trade organizations, are calling on Russian authorities to consider policy changes concerning clinical-trial regulation and intellectual property.
March 04, 2010
Merck KGaA has agreed to acquire Millipore for EUR 5.3 billion ($7.2 billion).
March 03, 2010
Nigel Darby, vice-president of biotechnologies at GE Healthcare Life Sciences and speaker at the Drug, Chemical, and Associated Technologies Association (DCAT) upcoming educational program on biologics, offers insight into the current and future state of upstream and downstream processing of biologics.